IGF1 Promotes Resistance to Apoptosis in Melanoma Cells through an Increased Expression of BCL2, BCL-X(L), and Survivin
- 1 June 2008
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 128 (6), 1499-1505
- https://doi.org/10.1038/sj.jid.5701185
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The IGF-I/IGF-I Receptor Pathway: Implications in the Pathophysiology of Thyroid CancerCurrent Medicinal Chemistry, 2005
- Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cellsInternational Journal of Cancer, 2005
- Activation of caspases-8 and -10 by FLIPLBiochemical Journal, 2004
- Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosisCell Death & Differentiation, 2004
- Inhibition of Death-Receptor Mediated Apoptosis in Human Adipocytes by the Insulin-Like Growth Factor I (IGF-I)/IGF-I Receptor Autocrine CircuitEndocrinology, 2004
- Evidence for a Novel, Caspase-8-Independent, Fas Death Domain-Mediated Apoptotic PathwayJournal of Biomedicine and Biotechnology, 2004
- Mechanisms by which IGF-I may promote cancer.Cancer Biology & Therapy, 2003
- Oligomerization Is a General Mechanism for the Activation of Apoptosis Initiator and Inflammatory ProcaspasesJournal of Biological Chemistry, 2003
- Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient MiceThe Journal of Immunology, 2002
- Mammalian Caspases: Structure, Activation, Substrates, and Functions During ApoptosisAnnual Review of Biochemistry, 1999